What We Make
High - Quality Tools Life Scientists Use to Seek Answers
Reagent " Tool Kits"
Specific combinations of chemistries that allow customers to carry out laboratory tests in the fields of cell biology; DNA, RNA and protein analysis; drug development; human identification; and molecular diagnostics.
Integrated Systems
Instrumentation that allows customers to automate their various research and lab procedures, increasing efficiency and precision.
Where Our Products Are Used
Pharmaceutical and Biotechnology Industries
Discovering new drugs to fight disease
Clinical and Molecular Diagnostics Laboratories
Detecting disease and determining therapies
Forensics and Paternity Laboratories
Discovering new drugs to fight disease
Government and Academic Research Laboratories
Discovering new drugs to fight disease
Applied Testing
Ensuring environmental food, water and plant safety and quality
Our Living Values
We have a 100 year mindset to keep asking questions that change the world. Promega exists on an evolutionary frontier where the values of science, business and human well-being intersect.
Read more about our purpose and values.
Integrated Systems
Instrumentation that allows customers to automate their various research and lab procedures, increasing efficiency and precision.
Spend Less Time Budgeting & More Time
Discovering!
A Novel Mechanism Underlying the Basic Defensive Response of Macrophag…
Abstract
Following inhalation of Mycobacterium tuberculosis, including bacillus Calmette–Guérin (BCG), pathogens enter and grow inside macrophages by taking advantage of their phagocytic mechanisms. Macrophages often fail to eliminate intracellular M. tuberculosis, leading to the induction of host macrophage death. Despite accumulating evidence, the molecular mechanisms underlying M. tuberculosis infection–induced cell death remain controversial. In this study, we show the involvement of two distinct pathways triggered by TLR2 and β2 integrin in BCG infection–induced macrophage apoptosis. First, BCG infection induced activation of ERK1/2, which in turn caused phosphorylation/activation of the proapoptotic protein Bim in mouse macrophage-like Raw 264.7 cells. BCG-infected Raw cells treated with U0126, an MEK/ERK inhibitor, led to the suppression of Bim phosphorylation alongside a remarkable increase in the number of viable macrophages. Small interfering RNA–mediated knockdown of Bim rescued the macrophages from the apoptotic cell death induced by BCG infection. Stimulation with Pam3CSK, a TLR2 agonist, induced macrophage apoptosis with a concomitant increase in the phosphorylation/activation of MEK/ERK and Bim. These observations indicate the important role of the TLR2/MEK/ERK/Bim pathway in BCG infection–induced macrophage apoptosis. Second, we used the β2 integrin agonists C3bi and fibronectin to show that the β2 integrin–derived signal was involved in BCG infection–induced apoptosis, independent of MEK/ERK activation. Interestingly, latex beads coated with Pam3CSK and C3bi were able to induce apoptosis in macrophages to the same extent and specificity as that induced by BCG. Taken together, two distinct pattern-recognition membrane receptors, TLR2 and β2 integrin, acted as triggers in BCG infection–induced macrophage apoptosis, in which MEK/ERK activation played a crucial role following the engagement of TLR2.